Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-11-17 | Raymond Urbanski M.D., Ph.D.(6) 47,851 * Includes 4,260 shares which Dr. Urbanski has the right to acquire within 60 days of October 30, 2017 pursuant to the exercise of outstanding options. Dr. Urbanski ceased being an executive officer of the Company on September 29, 2017. |
Data sourced from SEC filings. Last updated: 2025-10-11